Current and future antiretroviral treatment options in paediatric HIV infection

Carlo Giaquinto, Erika Morelli, Federica Fregonese, Osvalda Rampon, Martina Penazzato, Anita De Rossi, Ruggero D'Elia

Research output: Contribution to journalArticlepeer-review


Because of a lack of prevention policies or problems in implementing prevention of mother-to-child transmission (P-MTCT), most of the 1500 daily new HIV infections in children aged

Original languageEnglish
Pages (from-to)375-397
Number of pages23
JournalClinical Drug Investigation
Issue number6
Publication statusPublished - 2008


  • Antiretrovirals, therapeutic use
  • CCR5 receptor antagonists, therapeutic use
  • Children
  • Darunavir, therapeutic use
  • Efavirenz, therapeutic use
  • Elvitegravir, therapeutic use
  • Enfuvirtide, therapeutic use
  • Etravirine, therapeutic use

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'Current and future antiretroviral treatment options in paediatric HIV infection'. Together they form a unique fingerprint.

Cite this